⌘K

Login Start Free

Home/Filings/4/0001209191-21-010667

4//SEC Filing

D'Angio Paul 4

Accession 0001209191-21-010667

CIK 0001538210other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 2:47 PM ET

Size

5.3 KB

Accession

0001209191-21-010667

Insider Transaction Report

Form 4

Period: 2021-02-11

NexImmune, Inc.NEXI

Director

Transactions

Award
Stock Option (right to buy)
2021-02-11+9,556→ 45,312 total
Exercise: $17.00Exp: 2025-02-11→ Common Stock (9,556 underlying)

Footnotes (1)

[F1]These stock options will vest and become exercisable at the first anniversary of the vesting commencement date (2/11/21).

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1

filerCIK 0001843748

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 2:47 PM ET
Size: 5.3 KB

View on SEC.gov